RxDoctor Payments DataLook up a doctor →

Cole Linville, DO

Neuromuscular Medicine · Jacksonville, FLNPI 1851735377

Payments from drug & device makers

$31,906in general payments, 2019–2025

Across 409 payments — averaging $78.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$28K
  • Collegium Pharmaceutical, Inc.$867
  • Tersera Therapeutics LLC$312
  • Medtronic$264
  • Vertos Medical, Inc.$234
  • Azurity Pharmaceuticals, Inc.$209
  • plus $2K from 31 others

What the payments were for

  • Consulting fees$16,78853%
  • Travel & lodging$3,20810%
  • Food & beverage$11,91037%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few neuromuscular medicine providers in Floridato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$328,809
Medicare patients
315
Services billed
3,011

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
BelbucaBuprenorphine Hcl270$210,294
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen1,723$41,979
Buprenorphine100$18,955
Pregabalin491$13,016
Xtampza ErOxycodone Myristate25$10,928
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen412$10,012
Acetaminophen-CodeineAcetaminophen With Codeine426$8,141
EliquisApixaban11$7,766
Morphine Sulfate ErMorphine Sulfate260$6,823
JardianceEmpagliflozin11$6,330
Buprenorphine Hcl113$4,402
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl27$3,696
Tramadol Hcl423$3,506
Tramadol Hcl ErTramadol Hcl57$2,738
Gabapentin140$1,984

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Collegium Pharmaceutical, Inc.Belbuca, Xtampza Er$867$221,222295 claims
PfizerEliquis$35$7,76611 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few neuromuscular medicine providers in Floridaon file to place this against a meaningful peer group, so we don't.

Other neuromuscular medicine in Jacksonville

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →